MedTrace Logo

Pharmacogenetic Variation: Factors That May Affect the Efficacy and Safety of Medical Marijuana

NCT04083261 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 157

Last updated 2020-07-10

No results posted yet for this study

Summary

The primary purpose of this research is to identify genetic factors that may affect the efficacy and safety of medical marijuana, regardless of condition. The pharmacogenomics test detects DNA variants, which may affect the way drugs work and are metabolized in the body and/or detect potential side effects.

Conditions

  • New York Medical Marijuana Program Qualifying Conditions

Interventions

OTHER

DNA Genotek Oragene 600

Saliva-based DNA sample collection kit

Sponsors & Collaborators

  • Columbia Care Inc.

    lead OTHER

Principal Investigators

  • Rosemary Mazanet, MD · Columbia Care Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-11
Primary Completion
2020-03-30
Completion
2020-03-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04083261 on ClinicalTrials.gov